$ACLS
AXCELIS TECHNOLOGIES INC Stock $acls

$acls Overview Financials Valuation SEC Filings Company Website

2013 Q2 Form 10-Q Financial Statement

#000110465913037564 Filed on May 06, 2013

Income Statement

Concept	2013 Q2	2013 Q1	2012 Q1
Revenue	$47.50M	$40.73M	$55.01M
YoY Change	-19.65%	-25.96%	-40.96%
Cost Of Revenue	$30.76M	$27.78M	$34.47M
YoY Change	-15.31%	-19.4%	-44.48%
Gross Profit	$16.74M	$12.94M	$20.54M
YoY Change	-26.55%	-36.97%	-33.93%
Gross Profit Margin	35.24%	31.78%	37.33%
Selling, General & Admin	$12.01M	$11.79M	$14.38M
YoY Change	-5.61%	-18.02%	-14.77%
% of Gross Profit	71.73%	91.1%	70.03%
Research & Development	$8.503M	$9.206M	$11.70M
YoY Change	-18.85%	-21.32%	-1.0%
% of Gross Profit	50.8%	71.13%	56.97%
Depreciation & Amortization	$1.330M	$1.394M	$1.896M
YoY Change	-23.12%	-26.48%	0.74%
% of Gross Profit	7.95%	10.77%	9.23%
Operating Expenses	$20.13M	$22.43M	$28.93M
YoY Change	-13.79%	-22.47%	0.84%
Operating Profit	-$3.394M	-$9.487M	-$8.396M
YoY Change	503.91%	12.99%	-451.44%
Interest Expense	$51.00K	$0.00	$0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$362.0K	$832.0K	-$915.0K
YoY Change	-164.64%	-190.93%	106.08%
Pretax Income	-$3.756M	-$8.655M	-$9.311M
YoY Change	187700.0%	-7.05%	-578.71%
Income Tax	$263.0K	$333.0K	$717.0K
% Of Pretax Income
Net Earnings	-$4.000M	-$9.000M	-$10.00M
YoY Change	700.0%	-10.0%	-655.56%
Net Earnings / Revenue	-8.42%	-22.1%	-18.18%
Basic Earnings Per Share		-$0.08
Diluted Earnings Per Share	-$147.6K	-$0.08	-$373.1K
COMMON SHARES
Basic Shares Outstanding	108.3M shares	108.2M shares
Diluted Shares Outstanding		108.2M shares

Balance Sheet

Concept	2013 Q2	2013 Q1	2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$34.60M	$42.40M	$37.20M
YoY Change	2.37%	13.98%	-16.96%
Cash & Equivalents	$34.64M	$42.44M	$37.22M
Short-Term Investments
Other Short-Term Assets	$6.100M	$5.600M	$10.50M
YoY Change	-40.2%	-46.67%	-4.55%
Inventory	$96.41M	$98.73M	$128.7M
Prepaid Expenses
Receivables	$30.22M	$23.15M	$30.50M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$167.4M	$169.9M	$206.9M
YoY Change	-18.58%	-17.88%	-9.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$32.96M	$33.66M	$36.50M
YoY Change	-7.92%	-7.77%	-4.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$13.41M	$12.35M	$12.40M
YoY Change	15.57%	-0.39%	-34.39%
Total Long-Term Assets	$46.37M	$46.02M	$48.88M
YoY Change	-2.17%	-5.86%	-14.55%
TOTAL ASSETS
Total Short-Term Assets	$167.4M	$169.9M	$206.9M
Total Long-Term Assets	$46.37M	$46.02M	$48.88M
Total Assets	$213.8M	$216.0M	$255.8M
YoY Change	-15.51%	-15.58%	-10.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$16.19M	$13.79M	$17.90M
YoY Change	-8.02%	-22.94%	-53.02%
Accrued Expenses	$6.600M	$8.900M	$9.100M
YoY Change	-16.46%	-2.2%	-29.46%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$34.55M	$34.07M	$42.10M
YoY Change	-15.31%	-19.07%	-38.72%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$5.829M	$5.713M	$7.200M
YoY Change	-10.32%	-20.65%	-4.0%
Total Long-Term Liabilities	$5.829M	$5.713M	$7.200M
YoY Change	-10.32%	-20.65%	-4.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$34.55M	$34.07M	$42.10M
Total Long-Term Liabilities	$5.829M	$5.713M	$7.200M
Total Liabilities	$40.64M	$40.10M	$49.39M
YoY Change	-14.26%	-18.8%	-35.19%
SHAREHOLDERS EQUITY
Retained Earnings	-$335.5M	-$331.5M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.218M	$1.218M
YoY Change
Treasury Stock Shares	120.0K shares	120.0K shares
Shareholders Equity	$173.1M	$175.9M	$206.4M
YoY Change
Total Liabilities & Shareholders Equity	$213.8M	$216.0M	$255.8M
YoY Change	-15.51%	-15.58%	-10.65%

Cashflow Statement

Concept	2013 Q2	2013 Q1	2012 Q1
OPERATING ACTIVITIES
Net Income	-$4.000M	-$9.000M	-$10.00M
YoY Change	700.0%	-10.0%	-655.56%
Depreciation, Depletion And Amortization	$1.330M	$1.394M	$1.896M
YoY Change	-23.12%	-26.48%	0.74%
Cash From Operating Activities	-$8.920M	-$1.880M	-$9.700M
YoY Change	210.8%	-80.62%	701.65%
INVESTING ACTIVITIES
Capital Expenditures	-$190.0K	$150.0K	$141.0K
YoY Change	-24.0%	6.38%	-76.89%
Acquisitions
YoY Change
Other Investing Activities	$800.0K	$400.0K	$0.00
YoY Change			-100.0%
Cash From Investing Activities	$620.0K	$250.0K	-$140.0K
YoY Change	-358.33%	-278.57%	-77.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	350.0K	50.00K	980.0K
YoY Change	600.0%	-94.9%	122.73%
NET CHANGE
Cash From Operating Activities	-8.920M	-1.880M	-9.700M
Cash From Investing Activities	620.0K	250.0K	-140.0K
Cash From Financing Activities	350.0K	50.00K	980.0K
Net Change In Cash	-7.950M	-1.580M	-8.860M
YoY Change	159.8%	-82.17%	537.41%
FREE CASH FLOW
Cash From Operating Activities	-$8.920M	-$1.880M	-$9.700M
Capital Expenditures	-$190.0K	$150.0K	$141.0K
Free Cash Flow	-$8.730M	-$2.030M	-$9.841M
YoY Change	233.21%	-79.37%	440.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-924000	USD
CY2012Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-915000	USD
CY2012Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-9311000	USD
CY2012Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	717000	USD
CY2012Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	107067000	shares
CY2013Q1	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	368000	USD
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	40726000	USD
CY2013Q1	dei	Entity Registrant Name EntityRegistrantName	AXCELIS TECHNOLOGIES INC
CY2013Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001113232
CY2013Q1	dei	Document Type DocumentType	10-Q
CY2013Q1	dei	Document Period End Date DocumentPeriodEndDate	2013-03-31
CY2013Q1	dei	Amendment Flag AmendmentFlag	false
CY2013Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2012Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	47538000	USD
CY2013Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	108310881	shares
CY2013Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2012Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	7468000	USD
CY2012Q1	us-gaap	Sales Revenue Net SalesRevenueNet	55006000	USD
CY2012Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	29284000	USD
CY2012Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6583000	USD
CY2012Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7799000	USD
CY2012Q1	us-gaap	Restructuring Charges RestructuringCharges	2881000	USD
CY2012Q1	us-gaap	Operating Expenses OperatingExpenses	28932000	USD
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-8396000	USD
CY2012Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	9000	USD
CY2013Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	27783000	USD
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	22430000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-9487000	USD
CY2013Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	832000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-8655000	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	12943000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	56000	USD
CY2012Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9972000	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11058000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44986000	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	24843000	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	106000	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5056000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	175225000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	34413000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	12520000	USD
CY2012Q4	us-gaap	Assets Assets	222158000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10166000	USD
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7283000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	186076000	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	222158000	USD
CY2013Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q1	us-gaap	Assets Current AssetsCurrent	169942000	USD
CY2013Q1	us-gaap	Assets Assets	215957000	USD
CY2013Q1	us-gaap	Liabilities Current LiabilitiesCurrent	34070000	USD
CY2013Q1	us-gaap	Liabilities Liabilities	40104000	USD
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	175853000	USD
CY2013Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	215957000	USD
CY2013Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000000	shares
CY2012Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1700000	USD
CY2012Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	278000	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	6423000	USD
CY2012Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3932000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	29782000	USD
CY2012Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	456000	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5844000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	36082000	USD
CY2012Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	108000	USD
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	504643000	USD
CY2012Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1218000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-322477000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5020000	USD
CY2013Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2013Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	108405000	shares
CY2013Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	108285000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	108293000	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	108173000	shares
CY2013Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	120000	shares
CY2012Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	120000	shares
CY2012Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1896000	USD
CY2012Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	378000	USD
CY2012Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1082000	USD
CY2012Q1	us-gaap	Inventory Write Down InventoryWriteDown	248000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4810000	USD
CY2012Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8277000	USD
CY2012Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	385000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2162000	USD
CY2012Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-3818000	USD
CY2012Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	76000	USD
CY2012Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-6483000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-9697000	USD
CY2012Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	141000	USD
CY2012Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	3000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-144000	USD
CY2012Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	802000	USD
CY2012Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	175000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	977000	USD
CY2012Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-795000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-9659000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1879000	USD
CY2013Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	400000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	253000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	42441000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	37218000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46877000	USD
CY2013Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	800000	USD
CY2012Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1100000	USD
CY2013Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	65550000	USD
CY2012Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	72013000	USD
CY2013Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	17139000	USD
CY2012Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	12253000	USD
CY2013Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	16040000	USD
CY2012Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	15968000	USD
CY2013Q1	us-gaap	Inventory Net InventoryNet	98729000	USD
CY2013Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	35300000	USD
CY2012Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	33600000	USD
CY2013Q1	acls	Product Warranty Period ProductWarrantyPeriod	P1Y
CY2013Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1582000	USD
CY2012Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1801000	USD
CY2012Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3236000	USD
CY2011Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3697000	USD
CY2013Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	457000	USD
CY2012Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	842000	USD
CY2013Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	399000	USD
CY2012Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1078000	USD
CY2013Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-277000	USD
CY2012Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-225000	USD
CY2013Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1539000	USD
CY2012Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	3110000	USD
CY2012Q1	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	126000	USD
CY2013Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2103634	shares
CY2012Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2497101	shares
CY2013Q1	acls	Charges Related To Below Normal Production Capacity ChargesRelatedToBelowNormalProductionCapacity	500000	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2013Q1	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2013Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	108227000	shares
CY2013Q1	us-gaap	Restructuring And Related Cost Expected Cost RestructuringAndRelatedCostExpectedCost	1400000	USD
CY2013Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	34452000	USD
CY2013Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	6274000	USD
CY2013Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	22181000	USD
CY2013Q1	us-gaap	Cost Of Services CostOfServices	5602000	USD
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9206000	USD
CY2013Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5201000	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6590000	USD
CY2013Q1	us-gaap	Restructuring Charges RestructuringCharges	1801000	USD
CY2013Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	3000	USD
CY2013Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	829000	USD
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	333000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2078000	USD
CY2013Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8988000	USD
CY2012Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10028000	USD
CY2013Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	23150000	USD
CY2013Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	103000	USD
CY2013Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5519000	USD
CY2013Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	33663000	USD
CY2013Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	12352000	USD
CY2013Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	13793000	USD
CY2013Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8900000	USD
CY2013Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	356000	USD
CY2013Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5714000	USD
CY2013Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3768000	USD
CY2013Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	321000	USD
CY2013Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	49000	USD
CY2013Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-968000	USD
CY2013Q1	us-gaap	Inventory Write Down InventoryWriteDown	2211000	USD
CY2013Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5713000	USD
CY2013Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	108000	USD
CY2013Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	505478000	USD
CY2013Q1	us-gaap	Treasury Stock Value TreasuryStockValue	1218000	USD
CY2013Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-331465000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2950000	USD
CY2013Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1394000	USD
CY2013Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	56000	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	839000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1458000	USD
CY2013Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1672000	USD
CY2013Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	544000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5043000	USD
CY2013Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-843000	USD
CY2013Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	84000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	549000	USD
CY2013Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	150000	USD
CY2013Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-3000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2070000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Amortization Pension And Other Postretirement Benefit Plans Net Prior Service Cost Recognized In Net Periodic Pension Cost Net Of Tax OtherComprehensiveIncomeLossAmortizationPensionAndOtherPostretirementBenefitPlansNetPriorServiceCostRecognizedInNetPeriodicPensionCostNetOfTax	-8000	USD
CY2012Q1	acls	Charges Related To Below Normal Production Capacity ChargesRelatedToBelowNormalProductionCapacity	0	USD

Files In Submission

Name	View Source	Status
R7.htm	Edgar Link	pending
0001104659-13-037564-index-headers.html	Edgar Link	pending
0001104659-13-037564-index.html	Edgar Link	pending
0001104659-13-037564.txt	Edgar Link	pending
0001104659-13-037564-xbrl.zip	Edgar Link	pending
a13-8326_110q.htm	Edgar Link	pending
a13-8326_1ex31d1.htm	Edgar Link	pending
a13-8326_1ex31d2.htm	Edgar Link	pending
a13-8326_1ex32d1.htm	Edgar Link	pending
a13-8326_1ex32d2.htm	Edgar Link	pending
acls-20130331.xml	Edgar Link	completed
acls-20130331.xsd	Edgar Link	pending
acls-20130331_cal.xml	Edgar Link	unprocessable
acls-20130331_def.xml	Edgar Link	unprocessable
acls-20130331_lab.xml	Edgar Link	unprocessable
acls-20130331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACLS
AXCELIS TECHNOLOGIES INC Stock $acls

2013 Q2 Form 10-Q Financial Statement

#000110465913037564 Filed on May 06, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACLS AXCELIS TECHNOLOGIES INC Stock $acls

2013 Q2 Form 10-Q Financial Statement

#000110465913037564 Filed on May 06, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACLS
AXCELIS TECHNOLOGIES INC Stock $acls